On this blog and in my new book, Dosed: The Medication Generation Grows Up, I explore young people’s experiences with medication. And oftentimes, by exposing their ambivalence, even their resentment, toward their treatment from an early age, I end up implicitly questioning the value of early intervention for mental illness.

So in honor of the American Psychological Association’s Mental Health Month Blog Party Day, I want to address the question of whether I think early intervention is worth it.

How many kids take medications for mental health problems in the U.S. these days?

It’s a simple question, and one I’ve been getting asked a lot lately as I’ve been interviewed about my new book, Dosed: The Medication Generation Grows Up, about coming of age on psychiatric drugs.

And I’ve been embarrassed to hem and haw and not to have a single, easy answer.

Because here’s the thing: There are a lot of piecemeal stats from a lot of different sources, but they vary wildly, and there’s no single, unassailable source.

If some particularly controlling parents knew psychiatric medications were likely to have certain side effects, might they purposely inflict such treatment on their children as a way of controlling some of their offspring’s more unruly tendencies? Like, say, their kids’ rampant youthful sexuality?

That was the dystopian scenario some readers posed in response to my last blog post about psychiatric medications and sexual side effects.

I have to admit, it struck me as perhaps a little far-fetched that parents would put their children on medications solely for the side effects.

But, still, I wondered: If given a choice between two similar drugs, one with such side effects and one without, might a nervous parent not gravitate toward the medication that would quell their fears about burgeoning teenage sexuality?

Pediatrician and author Claudia Gold recently published a column about my book, Dosed: The Medication Generation Grows Up, over at The Boston Globe in which she highlighted an issue I’ve been meaning to address here for some time: Young people and medications’ sexual side effects.

The drugs most famous for interfering in the sexual realm are the SSRI antidepressants, like Prozac and Zoloft, which can cause loss of libido and problems with sexual arousal and orgasm. But mood stabilizers, such as Tegretol and Depakote, which are commonly used to treat bipolar disorder, also cause sexual side effects for many people

Both classes of drugs have been increasingly used in young people over the past couple of decades. But if these young people experience sexual side effects from the medications, what are the effects on their psychosexual development? Should we be worried?

In this blog, I have been writing about different facets of “the experience of medication” in young people who take psychiatric drugs for a variety of conditions.

I’m going to continue to do that, because there are many more topics I want to discuss (please feel free, as always, to make suggestions in the comments section if there are particular subjects you’d like me to write about).

However, if you’d like to read an account of what got me interested in this subject in the first place, you might want to check out the excerpt from my new book, Dosed: The Medication Generation Grows Up, which is over at Salon.com.

I borrowed the title for today’s post from Is It Me Or My Meds?, a very interesting book by the sociologist David Karp that examines how people taking antidepressants understand the drugs’ impact on different aspects of their identity.

I keep coming back to this question with regard to a new medication I’m taking and some rather unpleasant and difficult-to-place cognitive effects I’ve been experiencing.

Karp’s book asks the question broadly, invoking it in big, existential ways and also with regard to smaller, more prosaic topics such as side effects. This second point is actually more fraught than it might seem: It can be amazingly difficult to tell drug side effects from psychiatric symptoms, something I’ve been reminded of lately as I’ve had my meds adjusted.

My whole medication regimen has been in flux lately, because, as I think I mentioned in a previous post, I’m trying to get my migraines under control and the drugs used to treat migraines can interact with those used to treat anxiety and depression.

Lately, I’ve been feeling anxious, jumpy, and have been having trouble concentrating. But it took me a while to even think to tie this to my medications.

Given how long I’ve been taking meds (more than a decade), and the fact that I’ve written a book about the complicated and unexpected effects of psychiatric medications, you’d think I’d know better. But it just goes to show that one is inclined to think one’s moods are organic or innate. It takes a bit before you think to ask if it’s the drugs you’re taking.

I stayed up late the last few nights reading Jeffrey Eugenides’ The Marriage Plot, engrossed in large part by the subplot involving Leonard Bankhead, who suffers from bipolar disorder and what might be called a typically complicated relationship with both his manic phases and his medication.

The book is set in the early 1980s, which gives Leonard few viable options for pharmaceutical treatment. Now doctors often prescribe anticonvulsants such as Tegretol and Depakote, and atypical antipsychotics, but back then lithium was more or less the only choice.

Leonard began to experience depressions early in high school but wasn’t diagnosed or treated until his freshman year of college, when he began taking a low dose of lithium apparently without incident.

But as college graduation nears, he begins to chafe at the idea of taking the medication at all, which sets him on a terrible merry-go-round of breakdowns, high doses to get him back on track, side effects from the high doses and then rebellions against the side effects, followed by more breakdowns.